Bisphosphonates are bone-turnover modulating drugs used to treat various diseases such as certain cancers, bone metastasis, bone- and calcium-related disorders, Paget`s disease, osteoporosis and osteopenia. Recently, several preliminary reports have reported the insurgence of osteonecrosis of the mandible and/or maxilla, associated with intravenously administered bisphosphonates. This case series describes the effects of bisphosphonates used in the treatment of certain cancers on oral bone tissues.
|Data di pubblicazione:||2008|
|Titolo:||Maxillary bone necrosis following the use of bisphosphonates in patients with cancer: management and case series|
|Autori:||TORTORICI S; BURRUANO F; CARADONNA L; BUZZANCA ML AND DIFALCO P|
|Tipologia:||Articolo su rivista|
|Citazione:||TORTORICI S, BURRUANO F, CARADONNA L, & BUZZANCA ML AND DIFALCO P (2008). Maxillary bone necrosis following the use of bisphosphonates in patients with cancer: management and case series. RESEARCH JOURNAL OF BIOLOGICAL SCIENCES, 3(8), 925-929.|
|Altre informazioni significative:||Asian Science Citation Index|
|Appare nelle tipologie:||01 - Articolo su rivista|